11/15/2024
5:05 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:21 PM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
11/12/2024
4:10 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form RW | |
10/24/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
|
08/30/2024
8:08 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
3:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/24/2024
8:34 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:56 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/14/2024
4:12 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
11:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
05/07/2024
8:53 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
05/07/2024
8:56 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form ARS | |
05/07/2024
8:52 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
05/06/2024
4:26 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/29/2024
4:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form RW | |
04/26/2024
4:20 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:23 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
7:20 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/21/2024
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
2:47 PM | Altium Capital Management LP (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
02/07/2024
4:03 PM | ACORN BIOVENTURES, L.P. (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
01/31/2024
3:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
SCHWARTZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:15 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/12/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
12:35 PM | Altium Capital Management LP (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G | |
01/04/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
8:28 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
12/26/2023
8:29 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
8:20 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
11/28/2023
8:31 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Free CYCC Stock Alerts